Skip to main content

Advertisement

ADVERTISEMENT

Volume 32 - Issue 2 - February 2024

Featured Article

Patient Care
02/06/2024

Arnold H. Seto, MD, MPA, FSCAI

Director of Interventional Cardiology Research, School of Medicine,

University of California, Irvine, Orange, California;

Section Chief, Cardiology, Long Beach VA Medical Center, Long Beach, California

Arnold H. Seto, MD, MPA, FSCAI Direc...
End-tidal CO2 (EtCO2) measures the level of carbon dioxide that is released at the end of exhalation. Since the exhaled CO2 is much higher than the level in ambient air, EtCO2 is a sensitive marker of ventilatory effort, much more so than...
End-tidal CO2 (EtCO2) measures the level of carbon dioxide that is released at the end of exhalation. Since the exhaled CO2 is much higher than the level in ambient air, EtCO2 is a sensitive marker of ventilatory effort, much more so than...
End-tidal CO2 (EtCO2) measures...
02/06/2024
Cath Lab Digest
Peripheral Interventions
02/05/2024

Vishal Kapur, MD, FACC, FSCAI, RPVI

Director, Endovascular Intervention, Mount Sinai Morningside; Associate Professor, Division of Cardiology, Icahn School of Medicine at Mount Sinai; Associate Director, Endovascular Interventions,

Mount Sinai Hospital, New York, New York

Vishal Kapur, MD, FACC, FSCAI, RPVI ...
We have been using the Highlander™ 014 PTA Balloon Dilatation Catheter since it came out in early 2023. It is a great balloon because of its deliverability, non-compliance, and ability to expand in a controlled, uniform manner.
We have been using the Highlander™ 014 PTA Balloon Dilatation Catheter since it came out in early 2023. It is a great balloon because of its deliverability, non-compliance, and ability to expand in a controlled, uniform manner.
We have been using the...
02/05/2024
Cath Lab Digest
Calcium Corner
02/04/2024

Yousif Ahmad, BMedSci, BMBS, MRCP, PhD, FSCAI, FACC

Assistant Professor of Medicine (Cardiovascular Medicine); Director, Complex and High-Risk Interventional Procedures (CHIP) Program; Associate Program Director, Interventional Cardiology Fellowship, Yale School of Medicine, New Haven, Connecticut

Yousif Ahmad, BMedSci, BMBS, MRCP, Ph...
Cath lab managers, administrators, and people looking at the overheads should be aware of this change because it is going to alter the landscape. If you are doing a complex case using multiple devices, there is no longer the potential for a...
Cath lab managers, administrators, and people looking at the overheads should be aware of this change because it is going to alter the landscape. If you are doing a complex case using multiple devices, there is no longer the potential for a...
Cath lab managers,...
02/04/2024
Cath Lab Digest
Case Report
02/03/2024

Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM1;

Killian J. McCarthy, MB BCh BAO2
 

1Director, Vascular Intervention, Beth Israel Deaconess Medical Center; Section Head, Interventional Cardiology and Vascular Research, Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology; Assistant Professor of Medicine, Harvard Medical School, Boston, Massachusetts

 

2Interventional Fellow, Division of Cardiovascular Disease, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

Eric A. Secemsky, MD, MSc, RPVI, FACC...
Terumo Interventional Systems has introduced two new players to their interventional arsenal: the Runthrough NS Izanai Coronary Guidewire and Takeru PTCA Balloon Dilatation Catheter. Both devices are designed to improve pushability and...
Terumo Interventional Systems has introduced two new players to their interventional arsenal: the Runthrough NS Izanai Coronary Guidewire and Takeru PTCA Balloon Dilatation Catheter. Both devices are designed to improve pushability and...
Terumo Interventional Systems...
02/03/2024
Cath Lab Digest

Column

Clinical Editor's Corner
02/04/2024

Dr. Morton J. Kern with contributions from Drs.:

  • David J. Cohen, St. Francis Hospital, Roslyn, New York;
  • Kirk Garratt, Christiana Medical Center, Newark, Delaware;
  • Spencer King, Atlanta, Georgia;
  • Neal S. Kleiman, Methodist DeBakey Heart and Vascular Center, Houston, Texas;
  • Srihari S. Naidu, Westchester Medical Center, Valhalla, New York;
  • Matthew J. Price, Scripps Clinic, La Jolla, California;
  • Steve Ramee, Ochsner Clinic, New Orleans, Louisiana;
  • Chet Rihal, Mayo Clinic, Rochester, Minnesota;
  • Bonnie Weiner, Worcester, Massachusetts.
Dr. Morton J. Kern with contributions...
While the SGLT2 inhibitors and GLP-1 agonists were new to me in terms of their potential impact on our procedures, we will likely hold these medications before elective invasive and interventional cardiac procedures.
While the SGLT2 inhibitors and GLP-1 agonists were new to me in terms of their potential impact on our procedures, we will likely hold these medications before elective invasive and interventional cardiac procedures.
While the SGLT2 inhibitors and...
02/04/2024
Cath Lab Digest

Department

Letter to the Editor
02/03/2024

Sameer Mehta, MD, FACC; Yashendra Sethi, MD

Lumen Foundation, Miami, Florida

Sameer Mehta, MD, FACC; Yashendra Set...
In the labyrinth of global health, a paradigm shift is long overdue. For decades, we’ve clung to the traditional villains — smoking, diabetes, hypertension, and hyperlipidemia — as the principal architects of cardiovascular and...
In the labyrinth of global health, a paradigm shift is long overdue. For decades, we’ve clung to the traditional villains — smoking, diabetes, hypertension, and hyperlipidemia — as the principal architects of cardiovascular and...
In the labyrinth of global...
02/03/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement